Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLOMIPHENE Cause Left ventricular hypertrophy? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Left ventricular hypertrophy have been filed in association with CLOMIPHENE (Clomiphene Citrate). This represents 1.9% of all adverse event reports for CLOMIPHENE.

13
Reports of Left ventricular hypertrophy with CLOMIPHENE
1.9%
of all CLOMIPHENE reports
10
Deaths
2
Hospitalizations

How Dangerous Is Left ventricular hypertrophy From CLOMIPHENE?

Of the 13 reports, 10 (76.9%) resulted in death, 2 (15.4%) required hospitalization, and 2 (15.4%) were considered life-threatening.

Is Left ventricular hypertrophy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLOMIPHENE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does CLOMIPHENE Cause?

Off label use (75) Nausea (53) Exposure during pregnancy (49) Vomiting (49) Foetal exposure during pregnancy (41) Diarrhoea (34) Headache (34) Abortion spontaneous (31) Maternal exposure during pregnancy (31) Product use in unapproved indication (31)

What Other Drugs Cause Left ventricular hypertrophy?

AMLODIPINE (158) CLOZAPINE (149) TACROLIMUS (135) FUROSEMIDE (128) PANTOPRAZOLE (117) BISOPROLOL (114) SACUBITRIL\VALSARTAN (105) ASPIRIN (104) ROSUVASTATIN (94) CARVEDILOL (87)

Which CLOMIPHENE Alternatives Have Lower Left ventricular hypertrophy Risk?

CLOMIPHENE vs CLOMIPRAMINE CLOMIPHENE vs CLONAZEPAM CLOMIPHENE vs CLONIDINE CLOMIPHENE vs CLOPIDOGREL CLOMIPHENE vs CLOPIDOGREL BESILATE

Related Pages

CLOMIPHENE Full Profile All Left ventricular hypertrophy Reports All Drugs Causing Left ventricular hypertrophy CLOMIPHENE Demographics